Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

Delayed Data
As of Sep 29
 -1.14 / -4.61%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 30.00, with a high estimate of 48.00 and a low estimate of 21.00. The median estimate represents a +27.17% increase from the last price of 23.59.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 86.32%
Growthannually 9.81%


Growthquarterly 36.50%
Growthannually 6.29%
Key to the earnings and sales forecast charts.